{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:02:29Z","timestamp":1791216149106,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nrendo.2015.69","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T15:29:57Z","timestamp":1430839797000},"page":"478-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Disorders of sex development: effect of molecular diagnostics"],"prefix":"10.1038","volume":"11","author":[{"given":"John C.","family":"Achermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorahia","family":"Domenice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A. S. S.","family":"Bachega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Y.","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice B.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"BFnrendo201569_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrendo.2014.163","volume":"10","author":"S Eggers","year":"2014","unstructured":"Eggers, S., Ohnesorg, T. & Sinclair, A. Genetic regulation of mammalian gonad development. Nat. Rev. Endocrinol. 10, 673\u2013683 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrendo201569_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/adc.2006.098319","volume":"91","author":"IA Hughes","year":"2006","unstructured":"Hughes, I. A., Houk, C., Ahmed, S. F. & Lee, P. A. Consensus statement on management of intersex disorders. Arch. Dis. Child. 91, 554\u2013563 (2006).","journal-title":"Arch. Dis. Child."},{"key":"BFnrendo201569_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.1320530204","volume":"53","author":"LY Hsu","year":"1994","unstructured":"Hsu, L. Y. Phenotype\/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. Am. J. Med. Genet. 53, 108\u2013140 (1994).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrendo201569_CR4","first-page":"2967","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"J Griffin","year":"1995","unstructured":"Griffin, J., McPhaul, M., Russell, D. & Wilson, J. in The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, C. R. et al.) 2967\u20132979 (McGraw-Hill, 1995)."},{"key":"BFnrendo201569_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF00274705","volume":"56","author":"M De Marchi","year":"1981","unstructured":"De Marchi, M., Campagnoli, C., Ghiringhello, B., Ponzio, G. & Carbonara, A. Gonadal agenesis in a phenotypically normal female with positive H-Y antigen. Hum. Genet. 56, 417\u2013419 (1981).","journal-title":"Hum. Genet."},{"key":"BFnrendo201569_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00005792-199111000-00003","volume":"70","author":"GD Berkovitz","year":"1991","unstructured":"Berkovitz, G. D. et al. Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: its relevance to the understanding of sex differentiation. Medicine (Baltimore) 70, 375\u2013383 (1991).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrendo201569_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10577-012-9274-3","volume":"20","author":"S Eggers","year":"2012","unstructured":"Eggers, S. & Sinclair, A. Mammalian sex determination-insights from humans and mice. Chromosome Res. 20, 215\u2013238 (2012).","journal-title":"Chromosome Res."},{"key":"BFnrendo201569_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2265.2011.04076.x","volume":"75","author":"SF Ahmed","year":"2011","unstructured":"Ahmed, S. F. et al. UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin. Endocrinol. (Oxf.) 75, 12\u201326 (2011).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR9","first-page":"658","volume":"85","author":"SF Ahmed","year":"2000","unstructured":"Ahmed, S. F. et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 85, 658\u2013665 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<321::AID-AJMG17>3.0.CO;2-L","volume":"73","author":"MT McDonald","year":"1997","unstructured":"McDonald, M. T., Flejter, W., Sheldon, S., Putzi, M. J. & Gorski, J. L. XY sex reversal and gonadal dysgenesis due to 9p24 monosomy. Am. J. Med. Genet. 73, 321\u2013326 (1997).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrendo201569_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153417","volume":"14","author":"RM Baxter","year":"2013","unstructured":"Baxter, R. M. & Vilain, E. Translational genetics for diagnosis of human disorders of sex development. Annu. Rev. Genomics Hum. Genet. 14, 371\u2013392 (2013).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"BFnrendo201569_CR12","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1210\/jc.2003-030988","volume":"88","author":"RM Martin","year":"2003","unstructured":"Martin, R. M. et al. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J. Clin. Endocrinol. Metab. 88, 5739\u20135746 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00005792-200009000-00003","volume":"79","author":"BB Mendonca","year":"2000","unstructured":"Mendonca, B. B. et al. Male pseudohermaphroditism due to 17\u03b2-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 79, 299\u2013309 (2000).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrendo201569_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-0004.2008.00980.x","volume":"73","author":"M Barbaro","year":"2008","unstructured":"Barbaro, M. et al. Gene dosage imbalances in patients with 46,XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis. Clin. Genet. 73, 453\u2013464 (2008).","journal-title":"Clin. Genet."},{"key":"BFnrendo201569_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.10.001","volume":"729","author":"M Gundry","year":"2012","unstructured":"Gundry, M. & Vijg, J. Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants. Mutat. Res. 729, 1\u201315 (2012).","journal-title":"Mutat. Res."},{"key":"BFnrendo201569_CR16","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1093\/humrep\/deq167","volume":"25","author":"S Ledig","year":"2010","unstructured":"Ledig, S. et al. Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci. Hum. Reprod. 25, 2637\u20132646 (2010).","journal-title":"Hum. Reprod."},{"key":"BFnrendo201569_CR17","doi-asserted-by":"publisher","first-page":"e15392","DOI":"10.1371\/journal.pone.0015392","volume":"5","author":"M Tannour-Louet","year":"2010","unstructured":"Tannour-Louet, M. et al. Identification of de novo copy number variants associated with human disorders of sexual development. PLoS ONE 5, e15392 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrendo201569_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmg.2013.09.003","volume":"56","author":"A Norling","year":"2013","unstructured":"Norling, A. et al. Novel candidate genes for 46,XY gonadal dysgenesis identified by a customized 1 M array-CGH platform. Eur. J. Med. Genet. 56, 661\u2013668 (2013).","journal-title":"Eur. J. Med. Genet."},{"key":"BFnrendo201569_CR19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.drudis.2008.06.007","volume":"13","author":"M Shinawi","year":"2008","unstructured":"Shinawi, M. & Cheung, S. W. The array CGH and its clinical applications. Drug Discov. Today 13, 760\u2013770 (2008).","journal-title":"Drug Discov. Today"},{"key":"BFnrendo201569_CR20","doi-asserted-by":"publisher","first-page":"e17793","DOI":"10.1371\/journal.pone.0017793","volume":"6","author":"S White","year":"2011","unstructured":"White, S. et al. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PLoS ONE 6, e17793 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrendo201569_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG MacArthur","year":"2014","unstructured":"MacArthur, D. G. et al. Guidelines for investigating causality of sequence variants in human disease. Nature 508, 469\u2013476 (2014).","journal-title":"Nature"},{"key":"BFnrendo201569_CR22","doi-asserted-by":"publisher","first-page":"87ps23","DOI":"10.1126\/scitranslmed.3002695","volume":"3","author":"SF Kingsmore","year":"2011","unstructured":"Kingsmore, S. F. & Saunders, C. J. Deep sequencing of patient genomes for disease diagnosis: when will it become routine? Sci. Transl. Med. 3, 87ps23 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnrendo201569_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10897-013-9684-1","volume":"23","author":"A Swanson","year":"2014","unstructured":"Swanson, A., Ramos, E. & Snyder, H. Next generation sequencing is the impetus for the next generation of laboratory-based genetic counselors. J. Genet. Couns. 23, 647\u2013654 (2014).","journal-title":"J. Genet. Couns."},{"key":"BFnrendo201569_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000314917","volume":"4","author":"A Bashamboo","year":"2010","unstructured":"Bashamboo, A., Ledig, S., Wieacker, P., Achermann, J. C. & McElreavey, K. New technologies for the identification of novel genetic markers of disorders of sex development (DSD). Sex. Dev. 4, 213\u2013224 (2010).","journal-title":"Sex. Dev."},{"key":"BFnrendo201569_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/ejhg.2012.179","volume":"21","author":"FM Facio","year":"2013","unstructured":"Facio, F. M. et al. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur. J. Hum. Genet. 21, 261\u2013265 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrendo201569_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10897-013-9662-7","volume":"23","author":"FM Facio","year":"2014","unstructured":"Facio, F. M., Lee, K. & O'Daniel, J. M. A genetic counselor's guide to using next-generation sequencing in clinical practice. J. Genet. Couns. 23, 455\u2013462 (2014).","journal-title":"J. Genet. Couns."},{"key":"BFnrendo201569_CR27","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMra1312543","volume":"370","author":"LG Biesecker","year":"2014","unstructured":"Biesecker, L. G. & Green, R. C. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med. 370, 2418\u20132425 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201569_CR28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/gim.2013.183","volume":"16","author":"SP Strom","year":"2014","unstructured":"Strom, S. P. et al. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory. Genet. Med. 16, 510\u2013515 (2014).","journal-title":"Genet. Med."},{"key":"BFnrendo201569_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cen.12357","volume":"80","author":"RA Toledo","year":"2014","unstructured":"Toledo, R. A. & Dahia, P. L. Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with caution. Clin. Endocrinol. (Oxf.) 80, 23\u201324 (2014).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10897-013-9662-7","volume":"23","author":"FM Facio","year":"2013","unstructured":"Facio, F. M., Lee, K. & O'Daniel, J. M. A genetic counselor's guide to using next-generation sequencing in clinical practice. J. Genet. Couns. 23, 455\u2013462 (2013).","journal-title":"J. Genet. Couns."},{"key":"BFnrendo201569_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ajhg.2013.08.006","volume":"93","author":"MO Dorschner","year":"2013","unstructured":"Dorschner, M. O. et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am. J. Hum. Genet. 93, 631\u2013640 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo201569_CR32","doi-asserted-by":"publisher","first-page":"E333","DOI":"10.1210\/jc.2014-2605","volume":"100","author":"RM Baxter","year":"2014","unstructured":"Baxter, R. M. et al. Exome sequencing for the diagnosis of 46,XY disorders of sex development. J. Clin. Endocrinol. Metab. 100, E333\u2013E344 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg3493","volume":"14","author":"SH Katsanis","year":"2013","unstructured":"Katsanis, S. H. & Katsanis, N. Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 14, 415\u2013426 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrendo201569_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jcu.10207","volume":"31","author":"MG Pinette","year":"2003","unstructured":"Pinette, M. G., Wax, J. R., Blackstone, J. & Cartin, A. Normal growth and development of fetal external genitalia demonstrated by sonography. J. Clin. Ultrasound 31, 465\u2013472 (2003).","journal-title":"J. Clin. Ultrasound"},{"key":"BFnrendo201569_CR35","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1210\/jc.2001-011034","volume":"87","author":"O Pinhas-Hamiel","year":"2002","unstructured":"Pinhas-Hamiel, O. et al. Prenatal diagnosis of sex differentiation disorders: the role of fetal ultrasound. J. Clin. Endocrinol. Metab. 87, 4547\u20134553 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejogrb.2013.09.005","volume":"171","author":"C Colmant","year":"2013","unstructured":"Colmant, C., Morin-Surroca, M., Fuchs, F., Fernandez, H. & Senat, M. V. Non-invasive prenatal testing for fetal sex determination: is ultrasound still relevant? Eur. J. Obstet. Gynecol. Reprod. Biol. 171, 197\u2013204 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"BFnrendo201569_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/uog.6377","volume":"34","author":"A Tabor","year":"2009","unstructured":"Tabor, A., Vestergaard, C. H. & Lidegaard, O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet. Gynecol. 34, 19\u201324 (2009).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"BFnrendo201569_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/01.AOG.0000278820.54029.e3","volume":"110","author":"F Mujezinovic","year":"2007","unstructured":"Mujezinovic, F. & Alfirevic, Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet. Gynecol. 110, 687\u2013694 (2007).","journal-title":"Obstet. Gynecol."},{"key":"BFnrendo201569_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo, Y. M. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485\u2013487 (1997).","journal-title":"Lancet"},{"key":"BFnrendo201569_CR40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/1756-0500-5-476","volume":"5","author":"CF Wright","year":"2012","unstructured":"Wright, C. F., Wei, Y., Higgins, J. P. & Sagoo, G. S. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res. Notes 5, 476 (2012).","journal-title":"BMC Res. Notes"},{"key":"BFnrendo201569_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2011.1114","volume":"306","author":"SA Devaney","year":"2011","unstructured":"Devaney, S. A., Palomaki, G. E., Scott, J. A. & Bianchi, D. W. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 306, 627\u2013636 (2011).","journal-title":"JAMA"},{"key":"BFnrendo201569_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1196\/annals.1368.047","volume":"1075","author":"BG Zimmermann","year":"2006","unstructured":"Zimmermann, B. G., Holzgreve, W., Avent, N. & Hahn, S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Ann. NY Acad. Sci. 1075, 347\u2013349 (2006).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrendo201569_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/00016340601159124","volume":"86","author":"FM Liu","year":"2007","unstructured":"Liu, F. M. et al. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obstet. Gynecol. Scand. 86, 535\u2013541 (2007).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"BFnrendo201569_CR44","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/pd.1592","volume":"26","author":"CD Martinhago","year":"2006","unstructured":"Martinhago, C. D. et al. Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy. Prenat. Diagn. 26, 1219\u20131223 (2006).","journal-title":"Prenat. Diagn."},{"key":"BFnrendo201569_CR45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bpobgyn.2012.03.004","volume":"26","author":"M Hill","year":"2012","unstructured":"Hill, M., Barrett, A. N., White, H. & Chitty, L. S. Uses of cell free fetal DNA in maternal circulation. Best Pract. Res. Clin. Obstet. Gynaecol. 26, 639\u2013654 (2012).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"BFnrendo201569_CR46","first-page":"233","volume":"10","author":"F Alvarez-Nava","year":"1999","unstructured":"Alvarez-Nava, F., Gonzalez, S., Soto, S., Pineda, L. & Morales-Machin, A. Mixed gonadal dysgenesis: a syndrome of broad clinical, cytogenetic and histopathologic spectrum. Genet. Couns. 10, 233\u2013243 (1999).","journal-title":"Genet. Couns."},{"key":"BFnrendo201569_CR47","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00431-012-1754-0","volume":"171","author":"G Ocal","year":"2012","unstructured":"Ocal, G. et al. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does \u201cdisorders of sexual development (DSD)\u201d classification based on new Chicago consensus cover all sex chromosome DSD? Eur. J. Pediatr. 171, 1497\u20131502 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrendo201569_CR48","first-page":"255","volume":"12","author":"G Bagci","year":"2001","unstructured":"Bagci, G., Acar, H. & Tomruk, H. Different chromosome Y abnormalities in Turner syndrome. Genet. Couns. 12, 255\u2013261 (2001).","journal-title":"Genet. Couns."},{"key":"BFnrendo201569_CR49","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/ajmg.a.33475","volume":"152A","author":"M Shinawi","year":"2010","unstructured":"Shinawi, M. et al. Mixed gonadal dysgenesis in a child with isodicentric Y chromosome: Does the relative proportion of the 45,X line really matter? Am. J. Med. Genet. A 152A, 1832\u20131837 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrendo201569_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/gim.2013.77","volume":"16","author":"S Prakash","year":"2014","unstructured":"Prakash, S. et al. Single-nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of Turner syndrome. Genet. Med. 16, 53\u201359 (2014).","journal-title":"Genet. Med."},{"key":"BFnrendo201569_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2350-13-108","volume":"13","author":"R Hersmus","year":"2012","unstructured":"Hersmus, R. et al. SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal disorders of sex development (DSD) patients with a mosaic karyotype. BMC Med. Genet. 13, 108 (2012).","journal-title":"BMC Med. Genet."},{"key":"BFnrendo201569_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2265.1994.tb03922.x","volume":"40","author":"JM Lobaccaro","year":"1994","unstructured":"Lobaccaro, J. M. et al. Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on the Hind III polymorphism of the androgen receptor gene. Clin. Endocrinol. (Oxf.) 40, 297\u2013302 (1994).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR53","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/BF03345738","volume":"32","author":"S Bertelloni","year":"2009","unstructured":"Bertelloni, S. et al. 17\u03b2-hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence. J. Endocrinol. Invest. 32, 666\u2013670 (2009).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo201569_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1507\/endocrj.K11E-119","volume":"58","author":"N Richard","year":"2011","unstructured":"Richard, N. et al. Identification by array-comparative genomic hybridization (array-CGH) of a large deletion of luteinizing hormone receptor gene combined with a missense mutation in a patient diagnosed with a 46,XY disorder of sex development and application to prenatal diagnosis. Endocr. J. 58, 769\u2013776 (2011).","journal-title":"Endocr. J."},{"key":"BFnrendo201569_CR55","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jpag.2012.03.001","volume":"25","author":"G Russo","year":"2012","unstructured":"Russo, G. et al. 46,XY karyotype in a female phenotype fetus: a challenging diagnosis. J. Pediatr. Adolesc. Gynecol. 25, e77\u2013e79 (2012).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"BFnrendo201569_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4274\/jcrpe.v3i3.22","volume":"3","author":"G Ocal","year":"2011","unstructured":"Ocal, G. Current concepts in disorders of sexual development. J. Clin. Res. Pediatr. Endocrinol. 3, 105\u2013114 (2011).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"BFnrendo201569_CR57","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ajhg.2010.11.003","volume":"87","author":"A Pearlman","year":"2010","unstructured":"Pearlman, A. et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am. J. Hum. Genet. 87, 898\u2013904 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo201569_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrendo.2014.83","volume":"10","author":"JM Hutson","year":"2014","unstructured":"Hutson, J. M., Grover, S. R., O'Connell, M. & Pennell, S. D. Malformation syndromes associated with disorders of sex development. Nat. Rev. Endocrinol. 10, 476\u2013487 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrendo201569_CR59","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1073\/pnas.1010257108","volume":"108","author":"D Lourenco","year":"2013","unstructured":"Lourenco, D. et al. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc. Natl Acad. Sci. USA 108, 1597\u20131602 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo201569_CR60","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0092-8674(94)90041-8","volume":"79","author":"T Wagner","year":"1994","unstructured":"Wagner, T. et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111\u20131120 (1994).","journal-title":"Cell"},{"key":"BFnrendo201569_CR61","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmg.2012.07.012","volume":"55","author":"AZ Machado","year":"2012","unstructured":"Machado, A. Z. et al. Absence of inactivating mutations and deletions in the DMRT1 and FGF9 genes in a large cohort of 46,XY patients with gonadal dysgenesis. Eur. J. Med. Genet. 55, 690\u2013694 (2012).","journal-title":"Eur. J. Med. Genet."},{"key":"BFnrendo201569_CR62","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jmedgenet-2011-100255","volume":"48","author":"S Benko","year":"2011","unstructured":"Benko, S. et al. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J. Med. Genet. 48, 825\u2013830 (2011).","journal-title":"J. Med. Genet."},{"key":"BFnrendo201569_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1399-0004.2012.01879.x","volume":"83","author":"VA Arboleda","year":"2013","unstructured":"Arboleda, V. A. et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin. Genet. 83, 35\u201343 (2013).","journal-title":"Clin. Genet."},{"key":"BFnrendo201569_CR64","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1093\/hmg\/ddu074","volume":"23","author":"A Bashamboo","year":"2014","unstructured":"Bashamboo, A. et al. Mutations in the FOG2\/ZFPM2 gene are associated with anomalies of human testis determination. Hum. Mol. Genet. 23, 3657\u20133665 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo201569_CR65","doi-asserted-by":"publisher","first-page":"e1004340","DOI":"10.1371\/journal.pgen.1004340","volume":"10","author":"P Callier","year":"2014","unstructured":"Callier, P. et al. Loss of function mutation in the palmitoyl-transferase HHAT leads to syndromic 46,XY disorder of sex development by impeding Hedgehog protein palmitoylation and signaling. PLoS Genet. 10, e1004340 (2014).","journal-title":"PLoS Genet."},{"key":"BFnrendo201569_CR66","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ejhg.2014.130","volume":"23","author":"S Eggers","year":"2015","unstructured":"Eggers, S. et al. Whole exome sequencing combined with linkage analysis identifies a novel 3 bp deletion in NR5A1. Eur. J. Hum. Genet. 23, 486\u201393 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrendo201569_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-0032-1324726","volume":"30","author":"RJ Auchus","year":"2012","unstructured":"Auchus, R. J. & Miller, W. L. Defects in androgen biosynthesis causing 46,XY disorders of sexual development. Semin. Reprod. Med. 30, 417\u2013426 (2012).","journal-title":"Semin. Reprod. Med."},{"key":"BFnrendo201569_CR68","doi-asserted-by":"publisher","unstructured":"Khattab, A. et al. Pitfalls in hormonal diagnosis of 17-\u03b2 hydroxysteroid dehydrogenase III deficiency. J. Pediatr. Endocrinol. Metab. http:\/\/dx.doi.org\/10.1515\/jpem-2014-0295 .","DOI":"10.1515\/jpem-2014-0295"},{"key":"BFnrendo201569_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/cen.12012","volume":"78","author":"JY Wu","year":"2013","unstructured":"Wu, J. Y. et al. A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development. Clin. Endocrinol. (Oxf.) 78, 545\u2013550 (2013).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2265.2008.03392.x","volume":"70","author":"BB Mendonca","year":"2009","unstructured":"Mendonca, B. B., Domenice, S., Arnhold, I. J. & Costa, E. M. 46,XY disorders of sex development (DSD). Clin. Endocrinol. (Oxf.) 70, 173\u2013187 (2009).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR71","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(12)60071-3","volume":"380","author":"IA Hughes","year":"2012","unstructured":"Hughes, I. A. et al. Androgen insensitivity syndrome. Lancet 380, 1419\u20131428 (2012).","journal-title":"Lancet"},{"key":"BFnrendo201569_CR72","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1210\/jc.2002-021658","volume":"88","author":"KF Melo","year":"2003","unstructured":"Melo, K. F. et al. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J. Clin. Endocrinol. Metab. 88, 3241\u20133250 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2011.08.006","volume":"352","author":"J Jaaskelainen","year":"2011","unstructured":"Jaaskelainen, J. Molecular biology of androgen insensitivity. Mol. Cell. Endocrinol. 352, 4\u201312 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo201569_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.beem.2006.11.003","volume":"20","author":"IA Hughes","year":"2006","unstructured":"Hughes, I. A. & Deeb, A. Androgen resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20, 577\u2013598 (2006).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1210\/mend.14.3.0411","volume":"14","author":"D Robyr","year":"2000","unstructured":"Robyr, D., Wolffe, A. P. & Wahli, W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol. 14, 329\u2013347 (2000).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo201569_CR76","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ab.2010.03.034","volume":"402","author":"Y Weng","year":"2010","unstructured":"Weng, Y. et al. Analysis of testosterone and dihydrotestosterone in mouse tissues by liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal. Biochem. 402, 121\u2013128 (2010).","journal-title":"Anal. Biochem."},{"key":"BFnrendo201569_CR77","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1373\/clinchem.2008.103846","volume":"54","author":"S Shiraishi","year":"2008","unstructured":"Shiraishi, S. et al. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clin. Chem. 54, 1855\u20131863 (2008).","journal-title":"Clin. Chem."},{"key":"BFnrendo201569_CR78","first-page":"2821","volume":"81","author":"Z Hochberg","year":"1996","unstructured":"Hochberg, Z. et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 \u03b1-reductase 2 deficiency. J. Clin. Endocrinol. Metab. 81, 2821\u20132827 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00005792-199603000-00003","volume":"75","author":"BB Mendonca","year":"1996","unstructured":"Mendonca, B. B. et al. Male pseudohermaphroditism due to steroid 5 \u03b1-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 75, 64\u201376 (1996).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrendo201569_CR80","first-page":"3415","volume":"81","author":"O Hiort","year":"1996","unstructured":"Hiort, O. et al. Nonisotopic single strand conformation analysis of the 5 \u03b1-reductase type 2 gene for the diagnosis of 5 \u03b1-reductase deficiency. J. Clin. Endocrinol. Metab. 81, 3415\u20133418 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR81","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1530\/eje.1.01927","volume":"152","author":"S Thiele","year":"2005","unstructured":"Thiele, S., Hoppe, U., Holterhus, P. M. & Hiort, O. Isoenzyme type 1 of 5\u03b1-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5\u03b1-reductase type 2 deficient males. Eur. J. Endocrinol. 152, 875\u2013880 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo201569_CR82","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1365-2605.2009.01036.x","volume":"33","author":"L Maimoun","year":"2010","unstructured":"Maimoun, L. et al. Undervirilization in XY newborns may hide a 5\u03b1-reductase deficiency: report of three new SRD5A2 gene mutations. Int. J. Androl. 33, 841\u2013847 (2010).","journal-title":"Int. J. Androl."},{"key":"BFnrendo201569_CR83","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1373\/clinchem.2012.196501","volume":"59","author":"AO Chan","year":"2013","unstructured":"Chan, A. O. et al. Diagnosis of 5\u03b1-reductase 2 deficiency: is measurement of dihydrotestosterone essential? Clin. Chem. 59, 798\u2013806 (2013).","journal-title":"Clin. Chem."},{"key":"BFnrendo201569_CR84","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10508-005-4339-4","volume":"34","author":"PT Cohen-Kettenis","year":"2005","unstructured":"Cohen-Kettenis, P. T. Gender change in 46,XY persons with 5\u03b1-reductase-2 deficiency and 17\u03b2-hydroxysteroid dehydrogenase-3 deficiency. Arch. Sex. Behav. 34, 399\u2013410 (2005).","journal-title":"Arch. Sex. Behav."},{"key":"BFnrendo201569_CR85","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/cen.12572","volume":"82","author":"R Cassia Amaral","year":"2015","unstructured":"Cassia Amaral, R. et al. Quality of life in a large cohort of adult Brazilian patients with 46,XX and 46,XY disorders of sex development from a single tertiary centre. Clin. Endocrinol. (Oxf.) 82, 274\u2013279 (2015).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR86","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/cen.12572","volume":"82","author":"R Cassia Amaral","year":"2015","unstructured":"Cassia Amaral, R. et al. Quality of life of patients with 46,XX and 46,XY disorders of sex development. Clin. Endocrinol. (Oxf.) 82, 274\u2013279 (2015).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201569_CR87","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-0032-1324727","volume":"30","author":"EM Costa","year":"2012","unstructured":"Costa, E. M., Domenice, S., Sircili, M. H., Inacio, M. & Mendonca, B. B. DSD due to 5\u03b1-reductase 2 deficiency\u2014from diagnosis to long term outcome. Semin. Reprod. Med. 30, 427\u2013431 (2012).","journal-title":"Semin. Reprod. Med."},{"key":"BFnrendo201569_CR88","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1590\/S0004-27302011000800019","volume":"55","author":"G Hayashi","year":"2012","unstructured":"Hayashi, G. et al. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia. Arq. Bras. Endocrinol. Metabol. 55, 632\u2013637 (2012).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"BFnrendo201569_CR89","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1399-0004.2009.01274.x","volume":"76","author":"EL Silveira","year":"2009","unstructured":"Silveira, E. L. et al. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia. Clin. Genet. 76, 503\u2013510 (2009).","journal-title":"Clin. Genet."},{"key":"BFnrendo201569_CR90","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1399-0004.2011.01694.x","volume":"82","author":"K Sarafoglou","year":"2011","unstructured":"Sarafoglou, K., Lorentz, C. P., Otten, N., Oetting, W. S. & Grebe, S. K. Molecular testing in congenital adrenal hyperplasia due to 21\u03b1-hydroxylase deficiency in the era of newborn screening. Clin. Genet. 82, 64\u201370 (2011).","journal-title":"Clin. Genet."},{"key":"BFnrendo201569_CR91","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1043-2760(98)00067-8","volume":"9","author":"MG Forest","year":"1998","unstructured":"Forest, M. G., Morel, Y. & David, M. Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol. Metab. 9, 284\u2013289 (1998).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrendo201569_CR92","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1055\/s-0032-1324723","volume":"30","author":"MI New","year":"2012","unstructured":"New, M. I., Abraham, M., Yuen, T. & Lekarev, O. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia. Semin. Reprod. Med. 30, 396\u2013399 (2012).","journal-title":"Semin. Reprod. Med."},{"key":"BFnrendo201569_CR93","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0022-3476(84)80310-8","volume":"105","author":"M David","year":"1984","unstructured":"David, M. & Forest, M. G. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J. Pediatr. 105, 799\u2013803 (1984).","journal-title":"J. Pediatr."},{"key":"BFnrendo201569_CR94","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1210\/jc.2013-2895","volume":"99","author":"V Tardy-Guidollet","year":"2014","unstructured":"Tardy-Guidollet, V. et al. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002\u20132011). J. Clin. Endocrinol. Metab. 99, 1180\u20131188 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR95","doi-asserted-by":"publisher","first-page":"E1022","DOI":"10.1210\/jc.2014-1118","volume":"99","author":"MI New","year":"2014","unstructured":"New, M. I. et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J. Clin. Endocrinol. Metab. 99, E1022\u2013E1030 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR96","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1210\/jcem.86.12.8072","volume":"86","author":"MI New","year":"2001","unstructured":"New, M. I. et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J. Clin. Endocrinol. Metab. 86, 5651\u20135657 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR97","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1210\/jc.2006-1340","volume":"92","author":"T Hirvikoski","year":"2007","unstructured":"Hirvikoski, T. et al. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J. Clin. Endocrinol. Metab. 92, 542\u2013548 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR98","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser, P. W. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 4133\u20134160 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR99","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1081\/ERC-200044174","volume":"30","author":"SA Wudy","year":"2004","unstructured":"Wudy, S. A., Hartmann, M. F., Draper, N., Stewart, P. M. & Arlt, W. A male twin infant with skull deformity and elevated neonatal 17-hydroxyprogesterone: a prismatic case of P450 oxidoreductase deficiency. Endocr. Res. 30, 957\u2013964 (2004).","journal-title":"Endocr. Res."},{"key":"BFnrendo201569_CR100","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1210\/jc.2004-1374","volume":"90","author":"TH Johannsen","year":"2005","unstructured":"Johannsen, T. H. et al. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3\u03b2-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 90, 2076\u20132080 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR101","first-page":"204","volume":"68","author":"A Nordenstrom","year":"2007","unstructured":"Nordenstrom, A., Forest, M. G. & Wedell, A. A case of 3\u03b2-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis. Horm. Res. 68, 204\u2013208 (2007).","journal-title":"Horm. Res."},{"key":"BFnrendo201569_CR102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000336004","volume":"77","author":"DD Jeandron","year":"2012","unstructured":"Jeandron, D. D. & Sahakitrungruang, T. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3\u03b2-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency. Horm. Res. Paediatr. 77, 334\u2013338 (2012).","journal-title":"Horm. Res. Paediatr."},{"key":"BFnrendo201569_CR103","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2006-2345","volume":"92","author":"RR Scott","year":"2007","unstructured":"Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G. & Miller, W. L. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92, 2318\u20132322 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR104","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1515\/JPEM.2005.18.8.739","volume":"18","author":"B Ergun-Longmire","year":"2005","unstructured":"Ergun-Longmire, B. et al. Clinical, hormonal and cytogenetic evaluation of 46,XX males and review of the literature. J. Pediatr. Endocrinol. Metab. 18, 739\u2013748 (2005).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"BFnrendo201569_CR105","first-page":"690","volume":"76","author":"PY Fechner","year":"1993","unstructured":"Fechner, P. Y. et al. The role of the sex-determining region Y gene in the etiology of 46,XX maleness. J. Clin. Endocrinol. Metab. 76, 690\u2013695 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR106","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(66)92778-4","volume":"2","author":"MA Ferguson-Smith","year":"1966","unstructured":"Ferguson-Smith, M. A. X-Y chromosomal interchange in the aetiology of true hermaphroditism and of XX Klinefelter's syndrome. Lancet 2, 475\u2013476 (1966).","journal-title":"Lancet"},{"key":"BFnrendo201569_CR107","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/jc.2007-1115","volume":"93","author":"AT Maciel-Guerra","year":"2008","unstructured":"Maciel-Guerra, A. T. et al. XX maleness and XX true hermaphroditism in SRY-negative monozygotic twins: additional evidence for a common origin. J. Clin. Endocrinol. Metab. 93, 339\u2013343 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201569_CR108","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJMc1010311","volume":"364","author":"JJ Cox","year":"2011","unstructured":"Cox, J. J., Willatt, L., Homfray, T. & Woods, C. G. A SOX9 duplication and familial 46,XX developmental testicular disorder. N. Engl. J. Med. 364, 91\u201393 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201569_CR109","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1021\/jm800820b","volume":"51","author":"S Tomaselli","year":"2008","unstructured":"Tomaselli, S. et al. Solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based gadolinium(III)-chelate, a potential hepatospecific magnetic resonance imaging contrast agent. J. Med. Chem. 51, 6782\u20136792 (2008).","journal-title":"J. Med. Chem."},{"key":"BFnrendo201569_CR110","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/ajmg.a.35390","volume":"158A","author":"S Moalem","year":"2012","unstructured":"Moalem, S. et al. XX male sex reversal with genital abnormalities associated with a de novo SOX3 gene duplication. Am. J. Med. Genet. A 158A, 1759\u20131764 (2012).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrendo201569_CR111","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/pd.2329","volume":"29","author":"F Lonardo","year":"2009","unstructured":"Lonardo, F. et al. Prenatal diagnosis of 46,XX testicular DSD. Molecular, cytogenetic, molecular-cytogenetic, and ultrasonographic evaluation. Prenat. Diagn. 29, 998\u20131001 (2009).","journal-title":"Prenat. Diagn."},{"key":"BFnrendo201569_CR112","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/EJE-12-0136","volume":"167","author":"S Ledig","year":"2012","unstructured":"Ledig, S., Hiort, O., Wunsch, L. & Wieacker, P. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development. Eur. J. Endocrinol. 167, 119\u2013124 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo201569_CR113","volume-title":"GeneReviews","author":"H Ostrer","year":"2009","unstructured":"Ostrer, H. 46,XY disorder of sex development and 46,XY complete gonadal dysgenesis. GeneReviews [online] , (2009)."},{"key":"BFnrendo201569_CR114","first-page":"518","volume":"74","author":"C Dickerson","year":"2013","unstructured":"Dickerson, C. An overview of prenatal genetic screening and diagnostic testing. NC Med. J. 74, 518\u2013521 (2013).","journal-title":"NC Med. J."},{"key":"BFnrendo201569_CR115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3121\/cmr.4.2.123","volume":"4","author":"E McPherson","year":"2006","unstructured":"McPherson, E. Genetic diagnosis and testing in clinical practice. Clin. Med. Res. 4, 123\u2013129 (2006).","journal-title":"Clin. Med. Res."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.69","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T20:34:39Z","timestamp":1717878879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnrendo201569"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2015.69","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]},"assertion":[{"value":"5 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}